BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK. Portal thrombosis and steatosis after preoperativechemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 2006; 12(40): 6556-6558 [PMID: 17072991 DOI: 10.3748/wjg.v12.i40.6556]
URL: https://www.wjgnet.com/1007-9327/full/v12/i40/6556.htm
Number Citing Articles
1
Julianna V. F. Roddy, Suzanne M. Partridge, Michelle L. Rockey, Jane M. Pruemer, Jeff J. Guo, Shaili J. Desai, Malek M. Safa. Thromboembolic Events in Patients With Colorectal Cancer Receiving the Combination of Bevacizumab-Based Chemotherapy and Erythropoietin Stimulating AgentsAmerican Journal of Clinical Oncology 2010; 33(1): 36 doi: 10.1097/COC.0b013e31819cccaf
2
Chitra Viswanathan, Dhakshinamoorthy Ganeshan, Revathy B. Iyer. Oncologic Imaging : a Multidisciplinary Approach2023; : 692 doi: 10.1016/B978-0-323-69538-1.00041-0
3
Niharika Samala, Naga Chalasani. Drug-Induced Fatty Liver DiseaseCurrent Hepatology Reports 2018; 17(3): 260 doi: 10.1007/s11901-018-0418-6
4
Abhishek R. Keraliya, Michael H. Rosenthal, Katherine M. Krajewski, Jyothi P. Jagannathan, Atul B. Shinagare, Sree Harsha Tirumani, Nikhil H. Ramaiya. Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell TransplantationAmerican Journal of Roentgenology 2015; 205(4): 709 doi: 10.2214/AJR.15.14459
5
Chitra Viswanathan, Mylene T. Truong, Tara L. Sagebiel, Yulia Bronstein, Raghunandan Vikram, Madhavi Patnana, Paul M. Silverman, Priya R. Bhosale. Abdominal and Pelvic Complications of Nonoperative Oncologic TherapyRadioGraphics 2014; 34(4): 941 doi: 10.1148/rg.344140082
6
Meyler's Side Effects of Drugs2016; : 963 doi: 10.1016/B978-0-444-53717-1.00037-8
7
F.A. Goumas, F. Braun, D.C. Broering, M. Behrend. Side Effects of Drugs Annual 2009; 31: 589 doi: 10.1016/S0378-6080(09)03137-7
8
Ursa Brown-Glaberman, Rachael Swart, Tomislav Dragovich, Erika Bracamonte, Sandra Kurtin, Alison Stopeck. Hepatic injury associated with bevacizumab use in metastatic breast and colon cancers: a review of two casesCommunity Oncology 2008; 5(10): 539 doi: 10.1016/S1548-5315(11)70508-3
9
Yu Katayose, Michiaki Unno. Management of liver metastases from colorectal cancerClinical Journal of Gastroenterology 2010; 3(3): 128 doi: 10.1007/s12328-010-0155-z
10
F. Alessandrino, S.H. Tirumani, K.M. Krajewski, A.B. Shinagare, J.P. Jagannathan, N.H. Ramaiya, D.N. Di Salvo. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitorsClinical Radiology 2017; 72(7): 521 doi: 10.1016/j.crad.2017.04.003
11
Dhakshina Moorthy Ganeshan, Usama Salem, Chitra Viswanathan, Aparna Balachandran, Naveen Garg, Paul Silverman, Priya Bhosale. Complications of oncologic therapy in the abdomen and pelvis: a reviewAbdominal Imaging 2013; 38(1): 1 doi: 10.1007/s00261-012-9899-x
12
Yu Fujiwara, Takeshi Yamaguchi, Minoru Nakane. Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with ApixabanInternal Medicine 2021; 60(1): 53 doi: 10.2169/internalmedicine.5456-20
13
Stacy S. Shord, Linda R. Bressler, Lauryn A. Tierney, Sandra Cuellar, Amina George. Understanding and managing the possible adverse effects associated with bevacizumabAmerican Journal of Health-System Pharmacy 2009; 66(11): 999 doi: 10.2146/ajhp080455
14
Chitra Viswanathan, Revathy B. Iyer. Oncologic Imaging: A Multidisciplinary Approach2012; : 693 doi: 10.1016/B978-1-4377-2232-1.00040-1
15
S. Zalinski, O. Scatton, S. Jacqmin, V. Tacher, C. Brézault, O. Soubrane. Portal venous gas following chemotherapy for colorectal cancer liver metastasisEuropean Journal of Surgical Oncology (EJSO) 2009; 35(5): 557 doi: 10.1016/j.ejso.2008.09.003